FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1977711279> ?p ?o ?g. }

• W1977711279 endingPage "129" @default.
• W1977711279 startingPage "129" @default.
• W1977711279 abstract "Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine John W FunderPrince Henry&#39;s Institute, Clayton, Victoria, AustraliaAbstract: Spironolactone was first developed over 50 years ago as a potent mineralocorticoid receptor (MR) antagonist with undesirable side effects; it was followed a decade ago by eplerenone, which is less potent but much more MR-specific. From a marginal role as a potassium-sparing diuretic, spironolactone was shown to be an extraordinarily effective adjunctive agent in the treatment of progressive heart failure, as was eplerenone in subsequent heart failure trials. Neither acts as an aldosterone antagonist in the heart as the cardiac MR are occupied by cortisol, which becomes an aldosterone mimic in conditions of tissue damage. The accepted term “MR antagonist”, (as opposed to “aldosterone antagonist” or, worse, “aldosterone blocker”), should be retained, despite the demonstration that they act not to deny agonist access but as inverse agonists. The prevalence of primary aldosteronism is now recognized as accounting for about 10% of hypertension, with recent evidence suggesting that this figure may be considerably higher: in over two thirds of cases of primary aldosteronism therapy including MR antagonists is standard of care. MR antagonists are safe and vasoprotective in uncomplicated essential hypertension, even in diabetics, and at low doses they also specifically lower blood pressure in patients with so-called resistant hypertension. Nowhere are more than 1% of patients with primary aldosteronism ever diagnosed and specifically treated. Given the higher risk profile in patients with primary aldosteronism than that of age, sex, and blood pressure matched essential hypertension, on public health grounds alone the guidelines for first-line treatment of all hypertension should mandate inclusion of a low-dose MR antagonist.Keywords: spironolactone, eplerenone, primary aldosteronism, public health, inverse agonists" @default.
• W1977711279 created "2016-06-24" @default.
• W1977711279 creator A5019746134 @default.
• W1977711279 date "2013-10-01" @default.
• W1977711279 modified "2023-10-13" @default.
• W1977711279 title "Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine" @default.
• W1977711279 cites W137431462 @default.
• W1977711279 cites W1906463008 @default.
• W1977711279 cites W1966962224 @default.
• W1977711279 cites W1975716167 @default.
• W1977711279 cites W1990183776 @default.
• W1977711279 cites W1991861773 @default.
• W1977711279 cites W1993600102 @default.
• W1977711279 cites W1998359135 @default.
• W1977711279 cites W2002009078 @default.
• W1977711279 cites W2008269136 @default.
• W1977711279 cites W2021877422 @default.
• W1977711279 cites W2047109055 @default.
• W1977711279 cites W2052724934 @default.
• W1977711279 cites W2055719290 @default.
• W1977711279 cites W2058878775 @default.
• W1977711279 cites W2064532153 @default.
• W1977711279 cites W2070927058 @default.
• W1977711279 cites W2078558419 @default.
• W1977711279 cites W2093009414 @default.
• W1977711279 cites W2105265963 @default.
• W1977711279 cites W2108379419 @default.
• W1977711279 cites W2108548563 @default.
• W1977711279 cites W2111945961 @default.
• W1977711279 cites W2123184974 @default.
• W1977711279 cites W2129911320 @default.
• W1977711279 cites W2132715232 @default.
• W1977711279 cites W2142594979 @default.
• W1977711279 cites W2148114970 @default.
• W1977711279 cites W2150426711 @default.
• W1977711279 cites W2154015803 @default.
• W1977711279 cites W2156497356 @default.
• W1977711279 cites W2156903075 @default.
• W1977711279 cites W2318120578 @default.
• W1977711279 cites W2328127416 @default.
• W1977711279 cites W2341581017 @default.
• W1977711279 doi "https://doi.org/10.2147/ibpc.s13783" @default.
• W1977711279 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3796852" @default.
• W1977711279 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24133375" @default.
• W1977711279 hasPublicationYear "2013" @default.
• W1977711279 type Work @default.
• W1977711279 sameAs 1977711279 @default.
• W1977711279 citedByCount "75" @default.
• W1977711279 countsByYear W19777112792014 @default.
• W1977711279 countsByYear W19777112792015 @default.
• W1977711279 countsByYear W19777112792016 @default.
• W1977711279 countsByYear W19777112792017 @default.
• W1977711279 countsByYear W19777112792018 @default.
• W1977711279 countsByYear W19777112792019 @default.
• W1977711279 countsByYear W19777112792020 @default.
• W1977711279 countsByYear W19777112792021 @default.
• W1977711279 countsByYear W19777112792022 @default.
• W1977711279 countsByYear W19777112792023 @default.
• W1977711279 crossrefType "journal-article" @default.
• W1977711279 hasAuthorship W1977711279A5019746134 @default.
• W1977711279 hasBestOaLocation W19777112791 @default.
• W1977711279 hasConcept C126322002 @default.
• W1977711279 hasConcept C134018914 @default.
• W1977711279 hasConcept C164705383 @default.
• W1977711279 hasConcept C189135053 @default.
• W1977711279 hasConcept C2776292634 @default.
• W1977711279 hasConcept C2776379505 @default.
• W1977711279 hasConcept C2778198053 @default.
• W1977711279 hasConcept C2778525890 @default.
• W1977711279 hasConcept C2780072264 @default.
• W1977711279 hasConcept C2780233176 @default.
• W1977711279 hasConcept C71924100 @default.
• W1977711279 hasConcept C84393581 @default.
• W1977711279 hasConceptScore W1977711279C126322002 @default.
• W1977711279 hasConceptScore W1977711279C134018914 @default.
• W1977711279 hasConceptScore W1977711279C164705383 @default.
• W1977711279 hasConceptScore W1977711279C189135053 @default.
• W1977711279 hasConceptScore W1977711279C2776292634 @default.
• W1977711279 hasConceptScore W1977711279C2776379505 @default.
• W1977711279 hasConceptScore W1977711279C2778198053 @default.
• W1977711279 hasConceptScore W1977711279C2778525890 @default.
• W1977711279 hasConceptScore W1977711279C2780072264 @default.
• W1977711279 hasConceptScore W1977711279C2780233176 @default.
• W1977711279 hasConceptScore W1977711279C71924100 @default.
• W1977711279 hasConceptScore W1977711279C84393581 @default.
• W1977711279 hasLocation W19777112791 @default.
• W1977711279 hasLocation W19777112792 @default.
• W1977711279 hasLocation W19777112793 @default.
• W1977711279 hasLocation W19777112794 @default.
• W1977711279 hasOpenAccess W1977711279 @default.
• W1977711279 hasPrimaryLocation W19777112791 @default.
• W1977711279 hasRelatedWork W1971094050 @default.
• W1977711279 hasRelatedWork W1994621510 @default.
• W1977711279 hasRelatedWork W2312942238 @default.
• W1977711279 hasRelatedWork W2322243425 @default.
• W1977711279 hasRelatedWork W2325273457 @default.
• W1977711279 hasRelatedWork W2516746587 @default.
• W1977711279 hasRelatedWork W2782943268 @default.

• next